Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003–2006 and 2007–2010
To examine changes in seroprevalence of antibodies to hepatitis A virus (HAV) during a period in which universal vaccine recommendations for all U.S. children were implemented, results from serologic testing from the National Health and Nutrition Examination Survey (NHANES) from 2003–2010 were analyzed among 7,989 participants age 6–19 years, born in the U.S. in two birth cohorts (1986–1996 and 1997–2004). Overall prevalence increased over time from 24.4% in 2003–2006 to the highest ever reported (37.6%) in 2007–2010. Specifically, increases reached statistical significance in the birth cohort born in the years after implementation of vaccine recommendations (1997–2004), among those of race/ethnicity other than white, non-Hispanic, and among states where recommendations were implemented later. The greatest increase over time was among the subgroup of persons in states with early implementation who were of race/ethnicity other than white, non-Hispanic. Geographic region and birth cohort based on vaccine recommendations as well as race/ethnicity were the main predictors of seropositivity in 2007–2010. The increase in Hepatitis A seroprevalence occurred during a time of decreasing incidence and increasing vaccination, however race/ethnic disparities persist.
References
[1]
Wasley, A.; Samandari, T.; Bell, B.P. Incidence of hepatitis a in the United States in the era of vaccination. JAMA 2005, 294, 19–201.
[2]
Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis a through active or passive immunization: Recommendations of the Advisory Committee onIimmunization Practices (ACIP). MMWR Recomm. Rep. 1996, 45, 1–30.
[3]
Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis a through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 1999, 48, 1–37.
[4]
Fiore, A.E.; Wasley, A.; Bell, B.P. Prevention of hepatitis a through active or passive immunization: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2006, 55, 1–23.
[5]
Daniels, D.; Grytdal, S.; Wasley, A.; Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill. Summ. 2009, 58, 1–27.
[6]
Centers for Disease Control and Prevention. Viral Hepatitis Surveillance—United States, 2009. Available online: http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/Commentary.htm/ (accessed on 18 January 2012).
[7]
Centers for Disease Control and Prevention, U.S.D.H.H.S. Available online: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23/ (accessed on 17 May 2012).
[8]
Begg, N.; Miller, E. Role of epidemiology in vaccine policy. Vaccine 1990, 8, 180–189.
[9]
Bell, B.P.; Kruszon-Moran, D.; Shapiro, C.N.; Lambert, S.B.; McQuillan, G.M.; Margolis, H.S. Hepatitis a virus infection in the United States: Serologic results from the Third National Health and Nutrition Examination Survey. Vaccine 2005, 23, 5798–5806.
[10]
Klevens, R.M.; Kruszon-Moran, D.; Wasley, A.; Gallagher, K.; McQuillan, G.M.; Kuhnert, W.; Teshale, E.H.; Drobeniuc, J.; Bell, B.P. Seroprevalence of hepatitis a virus antibodies in the U.S.: Results from the National Health and Nutrition Examination Survey. Public Health Rep. 2011, 126, 522–532.
[11]
Centers for Disease Control and Prevention. Hepatitis a vaccination coverage among children aged 24–35 months—United States, 2006 and 2007. MMWR Morb. Mortal. Wkly. Rep. 2009, 58, 689–694.
[12]
Centers for Disease Control and Prevention. NHANES file documentation. Available online: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm/ (accessed on 16 March 2012).
[13]
US Department of Health and Human Services. Poverty Guidelines, Research, and Measurement. US Department of Health and Human Services website. Available online: http://aspe.hhs.gov/POVERTY/index.shtml/ (accessed 16 March 2012).
[14]
National Center for Health Statistics, CDC. National Health and Nutrition Examination Surveys Analytic Guidelines. Available online: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/analytical_guidelines.htm/ (accessed on 16 March 2012).
[15]
Korn, L. Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Surv. Methodol. 1998, 24, 193–201.
[16]
Klevens, R.M.; Miller, J.T.; Iqbal, K.; Thomas, A.; Rizzo, E.M.; Hanson, H.; Sweet, K.; Phan, Q.; Cronquist, A.; Khudyakov, Y.; et al. The evolving epidemiology of hepatitis a in the United States: Incidence and molecular epidemiology from population-based surveillance, 2005–2007. Arch. Intern. Med. 2010, 170, 1811–1818.
[17]
Centers for Disease Control and Prevention. National, State, and Local area vaccination coverage among children aged 19–35 months—United States, 2011. MMWR Morb. Mortal. Wkly. Rep. 2012, 61, 689–696.
[18]
Centers for Disease Control and Prevention. Vaccine for Childrens Prgram. Available online: http://www.cdc.gov/vaccines/programs/vfc/default.htm/ (accessed on 5 September 2012).
[19]
Dorell, C.G.; Yankey, D.; Byrd, K.K.; Murphy, T.V. Hepatitis a vaccination coverage among adolescents in the United States. Pediatrics 2012, 129, 213–221.
[20]
Centers for Disease Control and Prevention. Adult vaccination coverage—United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 2012, 61, 66–72.
[21]
Chodick, G.; Heymann, A.D.; Ashkenazi, S.; Kokia, E.; Shalev, V. Long-term trends in hepatitis a incidence following the inclusion of hepatitis a vaccine in the routine nationwide immunization program. J. Viral Hepat. 2008, 15, 62–65.
[22]
Vacchino, M.N. Incidence of hepatitis a in Argentina after vaccination. J. Viral Hepat. 2008, 15, 47–50.
[23]
Chironna, M.; Prato, R.; Sallustio, A.; Martinelli, D.; Tafuri, S.; Quarto, M.; Germinario, C. Hepatitis a in Puglia (South Italy) after 10 years of universal vaccination: Need for strict monitoring and catch-up vaccination. BMC Infect. Dis. 2012, 12, 271.
